10-Q: Gaxos.ai Reports Q3 2026 Results: Revenue Up, Losses Widen

Gaxos.ai Inc. filed its Q3 2026 Form 10-Q, reporting substantial revenue growth driven by administrative services and subscriptions, but also a significant increase in operating expenses and net loss.

Summary

• Gaxos.ai Inc. reported revenues of $2.81 million for Q3 2026, a significant increase from $498,271 in Q3 2025, driven by administrative services and subscription revenue.
• For the nine months ended September 30, 2026, revenues reached $7.08 million, up from $692,974 in the same period of 2025.
• Operating expenses increased substantially to $3.93 million in Q3 2026 from $1.81 million in Q3 2025, and from $4.38 million to $12.61 million for the nine-month periods.
• The company reported a net loss of $977,004 for Q3 2026, compared to a net loss of $1,140,873 in Q3 2025.
• For the nine months ended September 30, 2026, the net loss was $3,473,483, an increase from $3,197,507 in the prior year period.
• As of September 30, 2026, the company had $1.90 million in cash and $11.40 million in short-term investments, with a working capital of $12.69 million.
• The company raised approximately $6.3 million in net proceeds from its At The Market (ATM) offering and $3.17 million from warrant exercises during the nine months ended September 30, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to significant operating losses, increasing expenses, and reliance on future financing, despite revenue growth.

Positives

• Significant year-over-year revenue growth, with Q3 2026 revenues at $2.81 million, up from $498,271 in Q3 2025.
• Nine-month revenues reached $7.08 million, a substantial increase from $692,974 in the comparable period of 2025.
• The company has a healthy cash and short-term investment balance of approximately $13.3 million as of September 30, 2026.
• Successful capital raises through ATM offering and warrant exercises provided approximately $9.5 million in net financing during the first nine months of 2026.
• The company divested its gaming assets, generating a gain of $1.75 million for the nine months ended September 30, 2026.

Negatives

• Operating expenses increased significantly by 116.7% in Q3 2026 and 187.7% for the nine-month period compared to the prior year.
• Net loss attributable to common shareholders was $929,639 for Q3 2026, and $2,861,108 for the nine-month period.
• The company continues to operate at a loss and expects to generate operating losses in the foreseeable future.
• Advertising and marketing expenses saw a substantial increase of 189.6% in Q3 2026 and 449.1% for the nine-month period.
• The company's cash used in operating activities was $4.54 million for the nine months ended September 30, 2026.

Risks

• The company's ability to obtain additional funds for its operations.
• Financial performance, including revenues, cost of revenues, operating expenses, and the ability to attain and sustain profitability.
• Ability to compete effectively with existing competitors and new market entrants.
• Ability to effectively manage growth and future expenses.
• Ability to maintain, protect, and enhance intellectual property.
• Ability to comply with modified or new laws and regulations applying to its business, competitors, and industry.
• Ability to attract and retain qualified key management and technical personnel.

Future Outlook

The company expects to continue generating operating losses in the foreseeable future due to corporate overhead, R&D, and public company costs. However, it believes its current working capital and cash on hand are sufficient to meet operating needs for the next twelve months. The company plans to pursue R&D for its products, requiring additional capital.

Management Comments

• Gaxos.AI is building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative.
• The company's growing portfolio spans defense, health and wellness, entertainment, and productivity, bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes.
• We believe that our existing working capital and cash on hand will provide sufficient cash to enable the Company to meet its operating needs and debt requirements for the next twelve months from the issuance date of this report.

Industry Context

StockSavvy.ai notes that Gaxos.ai's focus on AI applications across various sectors like health, defense, and entertainment aligns with broader industry trends of AI integration. The company's revenue diversification into administrative services (RNK Health) and SaaS subscriptions (Gaxos Labs) reflects a strategy to capture recurring revenue streams, a common goal for technology companies.

Comparison to Industry Standards

• The company's revenue growth in administrative services and SaaS subscriptions is a positive indicator, aligning with industry trends where recurring revenue models are favored.
• However, the significant increase in operating expenses, particularly in advertising and marketing, outpaces revenue growth, which is a concern compared to more mature, profitable tech companies that manage expense ratios more tightly.
• The net loss position is common for early-stage technology companies investing heavily in R&D and market expansion, but sustained losses without a clear path to profitability can be a red flag compared to industry peers that have achieved profitability.

Legal Proceedings

• The company is not currently a party to any material legal proceedings and is not aware of any pending or threatened legal proceeding that could have a material adverse effect.

Related Party Transactions

• On October 10, 2024, Gaxos.ai Inc., RNK Health, and Nekwellness, LLC entered into an operating agreement for RNK Health, with Gaxos.ai owning 70% and Nekwellness owning 30%.

Stakeholder Impact

• Shareholders: Continued operating losses and reliance on future financing may impact stock value. Capital raises dilute existing ownership.
• Employees: Potential for increased R&D and growth initiatives may lead to new opportunities, but sustained losses could pose job security concerns.
• Creditors: The company's ability to meet obligations depends on its cash position and future financing.
• Customers: Continued development of AI solutions in health and productivity may offer enhanced services.

Next Steps

• Continue development and launch of AI applications through Gaxos Labs.
• Expand health optimization solutions through Gaxos Health.
• Pursue research and development of products requiring additional capital.
• Continue to manage corporate overhead, R&D, and public company costs.
• Seek additional debt or equity financing as needed to sustain operations and execute long-term business plans.

Key Dates

Recommendation

The company shows strong revenue growth and successful capital raises, indicating positive operational momentum. However, the significant increase in operating expenses and continued net losses, coupled with the acknowledgment of future financing needs, present considerable risks. A 'hold' recommendation reflects a balanced view of the growth potential against the ongoing financial challenges and operational burn rate.

Keywords

AI, Artificial Intelligence, Gaxos Labs, RNK Health, SaaS, Health Optimization, Generative AI, Technology